Cancer cells, including melanomas, tend to selectively utilize the beneficial functions of TGFβ signal transduction, including ANGPTL4 up-regulation (via the Smad signaling pathway), while eliminating the tumor suppressor function downstream to TGFβ [50, 51]. This evidence concerns the gene TGFB1 and neoplasm.